Interferon Can Block Telomere Erosion and in Rare Cases Result in Hepatocellular Carcinoma Development with Telomeric Repeat Binding Factor 1 Overexpression in Chronic Hepatitis C

Clinical Cancer Research

Volumn 9, Issue 14, 2003, Pages 5264-5270

  Igarashi, Masato ^a   Suda, Takeshi ^a   Hara, Hidenori ^b   Takimoto, Mitsuhiro ^a   Nomoto, Minoru ^a   Takahashi, Toru ^a   Okoshi, Shogo ^a   Kawai, Hirokazu ^a   Mita, Yusaku ^a   Waguri, Nobuo ^a   Aoyagi, Yutaka ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b Shibata Prefectural Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BINDING PROTEIN; INTERFERON; TELOMERIC REPEAT BINDING FACTOR 1; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RELATIVE TELOMERIC REPEAT CONTENT; RISK FACTOR; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; INTERFERON-ALPHA; LIVER; LIVER NEOPLASMS; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1;

EID: 10744228464     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. WHO. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral. Hepat., 6: 35-47, 1999.
2. Lindsay, K. L. Therapy of hepatitis C: overview. Hepatology, 26: 71S-77S, 1997.
3. International Interferon-α Hepatocellular Carcinoma Study Group. Effect of interferon-α on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study. Lancet, 351: 1535-1539, 1998.
4. Takimoto, M., Ohkoshi, S., Ichida, T., Takeda, Y., Nomoto, M., Asakura, H., Naito, A., Mori, S., Hata, K., Igarashi, K., Hara, H., Ohta, H., Soga, K., Watanabe, T., and Kamimura, T. Interferon inhibits progression of liver fibrosis and reduces the risk of hepatocarcinogenesis in patients with chronic hepatitis C: a retrospective multicenter analysis of 652 patients. Dig. Dis. Sci., 47: 170-176, 2002.
5. Yamaguchi, K., Omagari, K., Kinoshita, H., Yoshioka, S., Furusu, H., Takeshima, F., Nanashima, A., Yamaguchi, H., and Kohno, S. Development of hepatocellular carcinoma in a patient with chronic hepatitis C after 6 years of a sustained and complete response to IFN-α. J. Clin. Gastroenterol., 29: 207-209, 1999.
6. Miyano, S., Togashi, H., Shinzawa, H., Sugahara, K., Matsuo, T., Takeda, Y., Saito, K., Saito, T., Ishiyama, S., Kaneko, M., and Takahashi, T. Case report: occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C. J. Gastroenterol. Hepatol., 14: 928-930, 1999.
7. Blackburn, E. H., and Greider, C. W. Telomeres. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1995.
8. van Steensel, B., and de Lange, T. Control of telomere length by the human telomeric protein TRF1. Nature (Lond.), 385: 740-743, 1997.
9. Smith, S., Giriat, I., Schmitt. A., and de Lange, T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science (Wash. DC), 282: 1484-1487, 1998.
10. van Steensel, B., Smogorzewska, A., and de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell, 92: 401-413, 1998.
11. Griffith, J. D., Comeau, L., Rosenfield, S., Stansel, R. M., Bianchi, A., Moss, H., and de Lange, T. Mammalian telomeres end in a large duplex loop. Cell, 97: 503-514, 1999.
12. Romanov, S. R., Kozakiewicz, B. K., Holst, C. R., Stampfer, M. R., Haupt, L. M., and Tlsty, T. D. Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes. Nature (Lond.), 409: 633-637, 2001.
13. Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (Lond.), 406: 641-645, 2000.
14. Chin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S. L., Gottlieb, G. J., Greider, C. W., and DePinho, R. A. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell, 97: 527-538, 1999.
15. Watson, J. D. Origin of concatemeric T7 DNA. Nat. New Biol., 239: 197-201, 1972.
16. Isokawa, O., Suda, T., Aoyagi, Y., Kawai, H., Yokota, T., Takahashi, T., Tsukada, K., Shimizu, T., Mori, S., Abe, Y., Suzuki, Y., Nomoto, M., Mita, Y., Yanagi, M., Igarashi, H., and Asakura, H. Reduction of telomeric repeats as a possible predictor for development of hepatocellular carcinoma convenient evaluation by slot-blot analysis. Hepatology, 30: 408-412, 1999.
17. Kojima, H., Yokosuka, O., Imazeki, F., Saisho, H., and Omata, M. Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology, 112: 493-500. 1997.
18. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull. WHO, 79: 373-374, 2001.
19. Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., and Wollman, J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology, 1: 431-435, 1981.
20. Coombs, N. J., Gough, A. C., and Primrose, J. N. Optimization of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res., 27: e12, 1999.
21. Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., and Bacchetti, S. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J., 11: 1921-1929, 1992.
22. Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., and Allshire, R. C. Telomere reduction in human colorectal carcinoma and with ageing. Nature (Lond.), 346: 866-868, 1990.
23. Yatsuhashi, H., and Yano, M. Natural history of chronic hepatitis C. J. Gastroenterol. Hepatol., 15 (Suppl.): E111-E116, 2000.
24. Arase, Y., Ikeda, K., Murashima, N., Chayama, K., Tsubota, A., Koida, I., Suzuki, Y., Saitoh, S., Kobayashi, M., and Kumada, H. The long term efficacy of glycyrrhizin in chronic hepatitis C patients. Cancer (Phila.), 79: 1494-1500, 1997.
25. Shibata, M., Morizane, T., Uchida, T., Yamagami, T., Onozuka, Y., Nakano, M., Mitamura, K., and Ueno, Y. Irregular regeneration of hepatocytes and risk of hepatocellular carcinoma in chronic hepatitis and cirrhosis with hepatitis-C-virus infection. Lancet, 351: 1773-1777, 1998.
26. Hirashima, N., Mizokami, M., Orito, E., Koide, T., Itazu, I., Kumada, K., Sakakibara, K., Kano, H., and Lau, J. Y. Case report: development of hepatocellular carcinoma in a patient with chronic hepatitis C infection after a complete and sustained response to J. Gastroenterol. Hepatol., 11: 955-958, 1996.
27. Smogorzewska, A., van Steensel, B., Bianchi, A., Oelmann, S., Schaefer, M. R., Schnapp, G., and de Lange, T. Control of human telomere length by TRF1 and TRF2. Mol. Cell. Biol., 20: 1659-1668, 2000.
28. Kishi, S., Wulf, G., Nakamura, M., and Lu, K. P. Telomeric protein Pin2/TRF1 induces mitotic entry and apoptosis in cells with short telomeres and is down-regulated in human breast tumors. Oncogene, 20: 1497-1508, 2001.
29. Aragona, M., De Divitiis, O., La Torre, D., Panetta, S., D'Avella, D., Pontoriero, A., Morelli, M., La Torre, I., and Tomasello, F. Immunohistochemical TRF1 expression in human primary intracranial tumors. Anticancer Res., 21: 2135-2139, 2001.
30. Aragona, M., Buda, C. A., Panetta, S., Morelli, M., Giudice, A., Campagna, F. L., Pontoriero, A., Cascinu, S., and La Torre, F. Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors. Oncol. Rep., 7: 987-990, 2000.
31. Otsuka, T., Uchida, N., Arima, F., Shigematsu, H., Fukuyama, T., Maeda, M., Sugio, Y., Itoh, Y., and Niho, Y. Down-regulation of human telomeric protein TRF1 gene expression during myeloid differentiation in human hematopoietic cells. Int. J. Hematol., 71: 334-339, 2000.
32. Levy, L., Renard, C. A., Wei, Y., and Buendia, M. A. Genetic alterations and oncogenic pathways in hepatocellular carcinoma. Ann. N. Y. Acad. Sci., 963: 21-36, 2002.
33. Lee, J. S., and Thorgeirsson, S. S. Functional and genomic implications of global gene expression profiles in cell lines from human hepatocellular cancer. Hepatology, 35: 1134-1143, 2002.
34. Watanabe, T., and Muto, T. Colorectal carcinogenesis based on molecular biology of early colorectal cancer, with special reference to nonpolypoid (superficial) lesions. World J. Surg., 24: 1091-1097, 2000.